Literature DB >> 33777622

Not a Tumor-Nonspecific Orbital Inflammation.

James A Garrity1.   

Abstract

Objective  This study was aimed to illustrate the features and complexities of nonspecific orbital inflammation via discussion of two representative cases. Design  Present study is a retrospective case review. Setting  The study was conducted at a tertiary care medical center. Participants  Two patients with nonspecific orbital inflammation were participants of this retrospective study. Main Outcome Measures  Outcome of the study was disease-free patients and off all medications. Results  At follow-up, both patients are disease free and off all medications. Conclusion  Surgery plays a diagnostic and therapeutic role. While the clinical subtype is important for differential diagnosis and symptomatic treatment, the histologic subtype is similarly important. For inflammatory dacryoadenitis, surgery can be therapeutic. For extensive granulomatosis with polyangiitis, debulking surgery may allow better penetration of medications, especially rituximab. Thieme. All rights reserved.

Entities:  

Keywords:  dacryoadenitis; granulomatosis with polyangiitis; inflammation; orbit; orbital pseudotumor

Year:  2021        PMID: 33777622      PMCID: PMC7987399          DOI: 10.1055/s-0040-1722636

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  14 in total

1.  Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.

Authors:  Eric B Suhler; Lyndell L Lim; Robert M Beardsley; Tracy R Giles; Sirichai Pasadhika; Shelly T Lee; Alexandre de Saint Sardos; Nicholas J Butler; Justine R Smith; James T Rosenbaum
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

2.  Idiopathic sclerosing inflammation of the orbit: immunohistologic analysis and comparison with retroperitoneal fibrosis.

Authors:  J M McCarthy; V A White; G Harris; K B Simons; J Kennerdell; J Rootman
Journal:  Mod Pathol       Date:  1993-09       Impact factor: 7.842

3.  The surgical management of lacrimal gland pseudotumors.

Authors:  I Mombaerts; R O Schlingemann; R Goldschmeding; L A Noorduyn; L Koornneef
Journal:  Ophthalmology       Date:  1996-10       Impact factor: 12.079

4.  Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease.

Authors:  José Antonio Plaza; James A Garrity; Ahmet Dogan; Anuradha Ananthamurthy; Thomas E Witzig; Diva R Salomão
Journal:  Arch Ophthalmol       Date:  2011-04

5.  The nonspecific orbital inflammatory syndromes.

Authors:  J S Kennerdell; S C Dresner
Journal:  Surv Ophthalmol       Date:  1984 Sep-Oct       Impact factor: 6.048

6.  Acute orbital pseudotumors: classification and CT features.

Authors:  R A Nugent; J Rootman; W D Robertson; J S Lapointe; P B Harrison
Journal:  AJR Am J Roentgenol       Date:  1981-11       Impact factor: 3.959

7.  Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab.

Authors:  James A Garrity; Austin W Coleman; Eric L Matteson; Eric R Eggenberger; David M Waitzman
Journal:  Am J Ophthalmol       Date:  2004-12       Impact factor: 5.258

8.  Surgical debulking for idiopathic dacryoadenitis: a diagnosis and a cure.

Authors:  Ilse Mombaerts; J Douglas Cameron; Waruttaporn Chanlalit; James A Garrity
Journal:  Ophthalmology       Date:  2013-10-25       Impact factor: 12.079

Review 9.  Orbital inflammation: Biopsy first.

Authors:  Ilse Mombaerts; Geoffrey E Rose; James A Garrity
Journal:  Surv Ophthalmol       Date:  2016-03-17       Impact factor: 6.048

Review 10.  Idiopathic sclerosing inflammation of the orbit. A distinct clinicopathologic entity.

Authors:  J Rootman; M McCarthy; V White; G Harris; J Kennerdell
Journal:  Ophthalmology       Date:  1994-03       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.